147 related articles for article (PubMed ID: 37783406)
41.
Agrawal PK; Agrawal C; Blunden G
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744958
[TBL] [Abstract][Full Text] [Related]
42. Polarity of extracts and fractions of four Combretum (Combretaceae) species used to treat infections and gastrointestinal disorders in southern African traditional medicine has a major effect on different relevant in vitro activities.
Ahmed AS; McGaw LJ; Elgorashi EE; Naidoo V; Eloff JN
J Ethnopharmacol; 2014 Jun; 154(2):339-50. PubMed ID: 24681040
[TBL] [Abstract][Full Text] [Related]
43. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents.
Kanjanasirirat P; Suksatu A; Manopwisedjaroen S; Munyoo B; Tuchinda P; Jearawuttanakul K; Seemakhan S; Charoensutthivarakul S; Wongtrakoongate P; Rangkasenee N; Pitiporn S; Waranuch N; Chabang N; Khemawoot P; Sa-Ngiamsuntorn K; Pewkliang Y; Thongsri P; Chutipongtanate S; Hongeng S; Borwornpinyo S; Thitithanyanont A
Sci Rep; 2020 Nov; 10(1):19963. PubMed ID: 33203926
[TBL] [Abstract][Full Text] [Related]
44. Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals.
Piscotta FJ; Hoffmann HH; Choi YJ; Small GI; Ashbrook AW; Koirala B; Campbell EA; Darst SA; Rice CM; Brady SF
mSphere; 2021 Dec; 6(6):e0071121. PubMed ID: 34851166
[TBL] [Abstract][Full Text] [Related]
45. Natural Products as Potential Agents against SARS-CoV and SARSCoV- 2.
Raimundo E Silva JP; Acevedo CAH; de Souza TA; de Menezes RPB; Sessions ZL; Abreu LS; Cibulski SP; Scotti L; da Silva MS; Muratov EN; Scotti MT; Tavares JF
Curr Med Chem; 2021; 28(27):5498-5526. PubMed ID: 33550959
[TBL] [Abstract][Full Text] [Related]
46. Use of hyphenated analytical techniques to identify the bioactive constituents of Gunnera perpensa L., a South African medicinal plant, which potently inhibit SARS-CoV-2 spike glycoprotein-host ACE2 binding.
Invernizzi L; Moyo P; Cassel J; Isaacs FJ; Salvino JM; Montaner LJ; Tietjen I; Maharaj V
Anal Bioanal Chem; 2022 May; 414(13):3971-3985. PubMed ID: 35419694
[TBL] [Abstract][Full Text] [Related]
47. Anti-SARS-CoV-2
Elkousy RH; Said ZNA; Ali MA; Kutkat O; Abu El Wafa SA
Z Naturforsch C J Biosci; 2023 Sep; 78(9-10):365-376. PubMed ID: 37401758
[No Abstract] [Full Text] [Related]
48. Evaluating the
Choonong R; Ruangdachsuwan S; Churod T; Palabodeewat S; Punyahathaikul S; Juntarapornchai S; Ketsuwan K; Komaikul J; Masrinoul P; Kitisripanya T; Juengwatanatrakul T; Yusakul G; Kanchanapoom T; Putalun W
J Nat Prod; 2022 Dec; 85(12):2779-2788. PubMed ID: 36399766
[TBL] [Abstract][Full Text] [Related]
49. In vitro efficacy of Artemisia extracts against SARS-CoV-2.
Nie C; Trimpert J; Moon S; Haag R; Gilmore K; Kaufer BB; Seeberger PH
Virol J; 2021 Sep; 18(1):182. PubMed ID: 34496903
[TBL] [Abstract][Full Text] [Related]
50.
Zhurinov MZ; Miftakhova AF; Keyer V; Shulgau ZT; Solodova EV; Kalykberdiyev MK; Abilmagzhanov AZ; Talgatov ET; Ait S; Shustov AV
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630394
[TBL] [Abstract][Full Text] [Related]
51. Potential of
Foka FET; Manamela N; Mufamadi SM; Mufhandu HT
Biomed Res Int; 2022; 2022():5714035. PubMed ID: 36158879
[TBL] [Abstract][Full Text] [Related]
52. Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis.
Ebenezer O; Bodede O; Awolade P; Jordaan MA; Ogunsakin RE; Shapi M
Acta Pharm; 2022 Jun; 72(2):199-224. PubMed ID: 36651508
[TBL] [Abstract][Full Text] [Related]
53. COVID-19 Therapeutic Potential of Natural Products.
Low Z; Lani R; Tiong V; Poh C; AbuBakar S; Hassandarvish P
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298539
[TBL] [Abstract][Full Text] [Related]
54. In vitro potential antiviral SARS-CoV-19- activity of natural product thymohydroquinone and dithymoquinone from Nigella sativa.
Esharkawy ER; Almalki F; Hadda TB
Bioorg Chem; 2022 Mar; 120():105587. PubMed ID: 35026560
[TBL] [Abstract][Full Text] [Related]
55. Antiviral activity of medicinal plant-derived products against SARS-CoV-2.
de Oliveira JR; Antunes BS; do Nascimento GO; Kawall JCS; Oliveira JVB; Silva KGDS; Costa MAT; Oliveira CR
Exp Biol Med (Maywood); 2022 Oct; 247(20):1797-1809. PubMed ID: 35894129
[TBL] [Abstract][Full Text] [Related]
56. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach.
Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A
J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973
[TBL] [Abstract][Full Text] [Related]
57. Leveraging knowledge of Asian herbal medicine and its active compounds as COVID-19 treatment and prevention.
Liana D; Phanumartwiwath A
J Nat Med; 2022 Jan; 76(1):20-37. PubMed ID: 34623617
[TBL] [Abstract][Full Text] [Related]
58. In Silico Identification of Anti-SARS-CoV-2 Medicinal Plants Using Cheminformatics and Machine Learning.
Liang J; Zheng Y; Tong X; Yang N; Dai S
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615401
[TBL] [Abstract][Full Text] [Related]
59. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
60. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
